Celtic Therapeutics Raises $100 Million from PPD
Celtic Therapeutics, a private equity firm formed to acquire and invest in a diversified portfolio of 10 to 15 novel therapeutic product candidates, has received a $100 million investment commitment from PPD Inc. (Nasdaq: PPDI).
28 October 2009•3 mins read
